A recent medical study is challenging long-held assumptions about why the United States continues to experience a higher rate of early deaths compared with other high-income nations. While many people assume that drug overdoses, alcohol misuse, and suicide are the primary reasons, new findings published in JAMA Network Open suggest a different and more complex picture.
The research, also highlighted in a news release from Boston University, indicates that chronic diseases, especially those linked to heart and metabolic health, are responsible for the majority of excess deaths in the United States.
This article breaks down the findings in simple terms, explains what they mean for public health, and highlights why prevention may be more important than ever.
For years, public discussions about rising mortality rates in the United States have focused heavily on what are often called “deaths of despair.” This includes drug overdoses, alcohol-related harm, and suicide. While these issues are serious and growing, the new study shows they do not account for most of the gap in life expectancy between the U.S. and similar countries.
Instead, researchers found that cardiovascular and metabolic diseases are the leading contributors.
The study analyzed over 63 million deaths in the United States from 1999 to 2022 and compared them with mortality patterns in other wealthy countries. The results were striking: more than 900,000 excess deaths in 2022 alone were linked to conditions that could potentially have been prevented or better managed.
One of the most important findings is that heart disease remains the single largest driver of excess deaths in the United States.
According to the research:
When combined, cardiometabolic conditions explain more than half of the mortality gap between the United States and comparable nations.
Experts involved in the research noted that this pattern has remained consistent for more than two decades. Even as deaths from drug use and suicide have increased sharply in recent years, they still do not surpass the long-term impact of chronic disease.
The study does not ignore the impact of substance use and mental health crises. In fact, deaths related to drugs, alcohol, and suicide have increased significantly, especially since the opioid crisis intensified in the 2010s.
However, their overall contribution is smaller than many assume:
Together, these categories still represent a major public health issue, but they explain less of the mortality gap than chronic disease.
The rise in overdose deaths has been especially dramatic, with U.S. rates far exceeding those of peer nations. Yet even this surge has not surpassed the long-standing burden of cardiovascular disease.
Medical professionals interviewed in the study emphasize a key issue: many patients in the United States are receiving care too late.
A cardiologist cited in the report explained that patients often enter the healthcare system only after serious complications have already developed, such as:
At that stage, treatment is more complex and outcomes are often worse.
The main message from experts is that prevention is not being used effectively at a population level. Better screening, earlier diagnosis, and more consistent management of risk factors such as high blood pressure, obesity, and diabetes could significantly reduce premature deaths.
The study also found that the United States performs better in certain health areas compared to other countries. For example, cancer survival rates (excluding lung cancer) and influenza-related outcomes show improvement.
Researchers attribute this to strong medical innovation and access to advanced treatments.
However, progress in treating chronic cardiometabolic conditions has not kept pace. Lifestyle-related risks such as poor diet, physical inactivity, obesity, and limited preventive care continue to drive long-term health problems.
This imbalance helps explain why overall life expectancy in the United States has not improved as much as in other high-income nations.
One of the most important conclusions from the study is that chronic disease is not just a medical issue but a systemic one. It reflects broader factors such as:
Unlike sudden crises such as infectious outbreaks or overdoses, chronic conditions develop slowly over time. This makes them harder to address but also more preventable if detected early.
Researchers estimate that millions of deaths over the past two decades could have been avoided if the United States had similar health outcomes to other wealthy countries.
The study suggests that reducing the U.S. mortality gap will require a shift in focus. While addressing substance use disorders and mental health remains essential, equal or greater attention may need to be placed on:
Experts argue that strengthening preventive healthcare systems could have a larger impact on national life expectancy than focusing on any single cause of death.
The latest research published in JAMA Network Open and summarized by Boston University provides a clearer understanding of why the United States continues to lag behind other wealthy countries in life expectancy.
While “deaths of despair” such as overdose and suicide remain important public health challenges, the dominant factor behind excess mortality is still cardiovascular and metabolic disease.
The findings highlight a critical opportunity: improving prevention and early treatment could save hundreds of thousands of lives each year.
This article is for informational and educational purposes only. It is not intended to provide medical advice, diagnosis, or treatment. Health outcomes can vary widely between individuals. Always consult a qualified healthcare professional for personalized medical guidance or concerns regarding any condition or treatment.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.